Reflections from MedTech Conference 2025

Written by Nathalie Raad, Principal Consultant, Regulatory

This year’s MedTech Conference really drove home for me how fast things are changing in healthcare. I’m continuously blown away by the creative ideas medtech companies bring to the table. It’s exciting to see how our field turns big challenges into smart solutions. And even more exciting, knowing those innovations will help meet real patient needs.

But, my biggest takeaway by far – AI was everywhere. Both the practical and the more experimental kind. Speakers emphasized not adding AI just to say you did. Instead, find and implement the right tools in the right way to make the most of this potentially transformative technology. The companies that succeed will be the ones that pair AI with clear business goals, strong governance, and human-in-the-loop oversight.

While everyday AI is streamlining processes, GenAI remains a double-edged sword—offering efficiency but raising concerns over unpredictability and compliance. Wearables and connected care are also moving fast, opening doors for decentralized diagnostics and home-based care, which could completely reshape patient engagement. And, keep an eye on ISO 42001—it’s emerging as the standard for responsible AI management.

Regulatory frameworks are evolving to keep pace with innovation. There’s also a growing emphasis on global harmonization – FDA’s guidance and digital health initiatives, IMDRF’s work on PCCPs, and MHRA’s efforts toward a reliance model signal a global move toward harmonization, making market expansion faster and more predictable. The message from regulators was clear: engage early and be specific about what you want to achieve. For anyone in regulatory affairs, this means building strategies that anticipate iterative updates, leveraging Q-subs for early dialogue, and aligning with emerging standards like Good Machine Learning Practices.

It’s clear that MedTech is entering an era where data-driven insights, regulatory foresight, and operational agility will determine competitive advantage. The call to action is clear: embrace AI responsibly, engage regulators early, and design solutions that integrate seamlessly into clinical workflows. In this landscape, speed, trust, and patient-centricity are the ultimate differentiators.

Now is the time to get ahead of these changes. Invest in training so your teams are comfortable and capable with AI tools, identify the biggest pain-points in your workflow productivity, start mapping your product portfolio against PCCP opportunities, build internal playbooks for reliance pathways, and engage with regulators early – especially on AI-enabled devices. Regulatory teams that anticipate these shifts and embed flexibility into their strategies will be the ones enabling faster approvals and global market access.

I can’t wait to see how far we’ve come by next year’s MedTech!